Meneghini LF, et al. – Researchers reported on the achievement of physician-selected individualized HbA_1c targets in people with type 2 diabetes, newly or recently initiated on basal insulin, in a real-world setting. In addition, they examined the association of hypoglycemia with target achievement. In this 12-week, prospective, single-arm, observational study, almost all 3,139 evaluable participants (99.7%) had been set individualized targets by their physicians, with over half of all participants having HbA_1c targets between 7.0% and < 7.5%. Outcomes revealed no achievement of individualized HbA_1c targets by most participants using basal insulin. HbA_1c targets were achieved more frequently among participants who experienced symptomatic hypoglycemia.